These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33046553)

  • 1. MeCP2 Levels Regulate the 3D Structure of Heterochromatic Foci in Mouse Neurons.
    Ito-Ishida A; Baker SA; Sillitoe RV; Sun Y; Zhou J; Ono Y; Iwakiri J; Yuzaki M; Zoghbi HY
    J Neurosci; 2020 Nov; 40(45):8746-8766. PubMed ID: 33046553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MeCP2 is required for global heterochromatic and nucleolar changes during activity-dependent neuronal maturation.
    Singleton MK; Gonzales ML; Leung KN; Yasui DH; Schroeder DI; Dunaway K; LaSalle JM
    Neurobiol Dis; 2011 Jul; 43(1):190-200. PubMed ID: 21420494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rett syndrome-causing mutations compromise MeCP2-mediated liquid-liquid phase separation of chromatin.
    Wang L; Hu M; Zuo MQ; Zhao J; Wu D; Huang L; Wen Y; Li Y; Chen P; Bao X; Dong MQ; Li G; Li P
    Cell Res; 2020 May; 30(5):393-407. PubMed ID: 32111972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic changes in Histone H3 lysine 9 acetylation localization patterns during neuronal maturation require MeCP2.
    Thatcher KN; LaSalle JM
    Epigenetics; 2006; 1(1):24-31. PubMed ID: 17464364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Setdb1-mediated histone H3K9 hypermethylation in neurons worsens the neurological phenotype of Mecp2-deficient mice.
    Jiang Y; Matevossian A; Guo Y; Akbarian S
    Neuropharmacology; 2011 Jun; 60(7-8):1088-97. PubMed ID: 20869373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA sequencing and proteomics approaches reveal novel deficits in the cortex of
    Pacheco NL; Heaven MR; Holt LM; Crossman DK; Boggio KJ; Shaffer SA; Flint DL; Olsen ML
    Mol Autism; 2017; 8():56. PubMed ID: 29090078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MeCP2 nuclear dynamics in live neurons results from low and high affinity chromatin interactions.
    Piccolo FM; Liu Z; Dong P; Hsu CL; Stoyanova EI; Rao A; Tjian R; Heintz N
    Elife; 2019 Dec; 8():. PubMed ID: 31868585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippocampal CA1 pyramidal neurons of Mecp2 mutant mice show a dendritic spine phenotype only in the presymptomatic stage.
    Chapleau CA; Boggio EM; Calfa G; Percy AK; Giustetto M; Pozzo-Miller L
    Neural Plast; 2012; 2012():976164. PubMed ID: 22919518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
    Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rett syndrome and MeCP2.
    Liyanage VR; Rastegar M
    Neuromolecular Med; 2014 Jun; 16(2):231-64. PubMed ID: 24615633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATRX Contributes to MeCP2-Mediated Pericentric Heterochromatin Organization during Neural Differentiation.
    Marano D; Fioriniello S; Fiorillo F; Gibbons RJ; D'Esposito M; Della Ragione F
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.
    Chen RZ; Akbarian S; Tudor M; Jaenisch R
    Nat Genet; 2001 Mar; 27(3):327-31. PubMed ID: 11242118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders.
    Baker SA; Chen L; Wilkins AD; Yu P; Lichtarge O; Zoghbi HY
    Cell; 2013 Feb; 152(5):984-96. PubMed ID: 23452848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal morphology in MeCP2 mouse models is intrinsically variable and depends on age, cell type, and Mecp2 mutation.
    Wang IT; Reyes AR; Zhou Z
    Neurobiol Dis; 2013 Oct; 58():3-12. PubMed ID: 23659895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MeCP2, A Modulator of Neuronal Chromatin Organization Involved in Rett Syndrome.
    Martínez de Paz A; Ausió J
    Adv Exp Med Biol; 2017; 978():3-21. PubMed ID: 28523538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
    Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism.
    Swanberg SE; Nagarajan RP; Peddada S; Yasui DH; LaSalle JM
    Hum Mol Genet; 2009 Feb; 18(3):525-34. PubMed ID: 19000991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations.
    Vecsler M; Ben Zeev B; Nudelman I; Anikster Y; Simon AJ; Amariglio N; Rechavi G; Baasov T; Gak E
    PLoS One; 2011; 6(6):e20733. PubMed ID: 21695138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome.
    Peddada S; Yasui DH; LaSalle JM
    Hum Mol Genet; 2006 Jun; 15(12):2003-14. PubMed ID: 16682435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
    Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
    Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.